Abstract: Gramicidin S (GS) is a 10-residue cyclic b-sheet peptide with lytic activity against the membranes of both microbial and human cells, i.e. it possesses little to no biologic specificity for either cell type. Structure-activity studies of de novo-designed 14-residue cyclic peptides based on GS have previously shown that higher specificity against microbial membranes, i.e. a high 
The problem of pathogens that are becoming resistant to conventional antibiotics has emerged as a prominent global health concern, as the number of resistant bacterial strains has increased significantly in the last decades (1) . The issue has brought attention to the need for alternative antimicrobial agents that bacteria have not or are unlikely to develop resistance mechanisms against. In the past two decades, a number of naturally occurring cationic antimicrobial peptides have been identified and characterized in a wide range of organisms (2) (3) (4) (5) . In contrast with conventional antibiotics that specifically inhibit essential molecules such as enzymes involved in cell wall synthesis, transcription or translation, these peptides are thought to directly interact with and disrupt the stability of the microbial membrane (6). Therefore, killing is rapid (minutes vs. hours or days) fairly nonspecific (active against a broad spectrum of gram-positive and gram-negative bacteria) and does not produce bacteria resistant to this mode of action (7) .
Gramicidin S (GS) is an antimicrobial peptide that has
been the subject of numerous structure-activity studies (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . It is active against both gram-negative and grampositive bacteria (13) , but has had limited applications as a therapeutic antimicrobial agent because of its high toxicity to human cells. GS is a cyclic 10-residue b-sheet peptide sharing features common to many antimicrobial peptides, including an overall positive (+2) charge, secondary structure in the membrane, and some degree of amphipathicity (nonpolar and polar faces). Recently, efforts have been made to design peptides related to GS that increase specificity toward microbial cells vs. mammalian cells, based on the differences in membrane lipid composition between microbial cells and human cells. Attempts have been made to dissociate antimicrobial activity from hemolytic activity by changing parameters such as ring size, b-sheet structure, and amphipathicity (9, 10, 14) . GS analogs of four to 14
amino acids were prepared and tested for biologic activity.
Although a de novo-designed peptide, GS14, enabled dissociation between antimicrobial activity and hemolytic activity, the result [poor antimicrobial activity and strong hemolytic activity, i.e. a low therapeutic index (TI)] was opposite to that desired (10) . Nevertheless, the study demonstrated that it was possible to alter membrane specificity between microbial and human cells by sequence manipulation. In a subsequent study of GS14 analogs, introducing d-enantiomers in the ten b-strand positions that normally contain l-amino acids reversed this activity profile. These (GS14K4) (14) .
In this study, we continue to investigate the effects of enantiomeric substitutions in GS14. Here, we substitute single d-amino acids specifically at position 4 that span a wide range of side-chain hydrophobicities. These substitutions, in addition to disrupting b-sheet structure and affecting amphipathicity, also change the overall peptide hydrophobicity. Moreover, to determine which of these parameters are responsible for the changes in biologic activity, we also studied GS14 peptides with the corresponding l-amino acid at position 4 to compare differences in structure, amphipathicity and activity between d-and l-diastereomers. In addition, we substituted the achiral amino acid glycine at position 4 to examine its effect on disruption of b-sheet structure and biologic activity in the L-enantiomers although substitution of a hydrophobic D-amino acid increases the nonpolar face hydrophobicity. These results further support the role of hydrophobicity of the nonpolar face as a major influence on microbial specificity, but also highlights the importance of a disrupted b-sheet structure on antimicrobial activity.
Lee et al . d-Amino acid substitutions in antimicrobial peptides absence of a side-chain. We find here that all l-substituted peptides maintained a b-sheet structure, and generally have strong hemolytic activity and weak antimicrobial activity.
Although the Gly substitution disrupted b-sheet structure, it did not significantly improve hemolytic or antimicrobial activity over the l-substitutions. The d-substitutions disrupted b-sheet structure, with varying improvements in hemolytic and antimicrobial activity. Polar d-substitutions provided the best improvements in TI, with the d-Lys substituted peptide yielding the highest therapeutic indices in this study against all microorganisms tested. These results support the hypothesis that an optimal nonpolar face hydrophobicity coupled with a disrupted b-sheet structure can maximize microbial specificity in the GS14 cyclic b-sheet structural template.
Materials and Methods

Microbial strains
Strains used in the antimicrobial assays include the yeast (elution conditions ranged from 20 to 70% B) and purified fractions were lyophilized to a dry powder.
Circular dichroism spectroscopy
Circular dichroism (CD) scans were performed as described previously (10) . Briefly, scans were obtained on a Jasco J-720
Spectrapolarimeter (Jasco, Easton, MD, USA) using a 0. 
Hemolysis assays
The hemolytic activity for each peptide was determined by making twofold serial dilutions of the peptide sample in a microtiter plate to a final volume of 100 lL, and adding 100 lL of washed human erythrocytes (RBC) in a 1% suspension based on packed cell volume. Concentrations of peptide stock solutions were determined by amino acid analysis. Plates were incubated for 2 or 24 h at 37°C and the minimal peptide concentration for complete RBC lysis was considered to be the hemolytic activity for that peptide, reported in lg/mL (except in Fig. 5 ). The hemolytic activity bar graph in Fig. 5 is displayed in reciprocal units,
, for the purpose of using high values to show the peptides with strong hemolytic activity (in contrast with the values reported in lg/mL, which are inversely proportional to activity). There was never greater than a twofold change in activity for any peptide from 2 to 24 h. A negative control was determined from samples of 200 lL of 1% RBC with no peptide present.
Analytical HPLC
Runs were performed on a Hewlett Packard 1100 chromatograph using a Zorbax 300 SB C 8 column (15 · 0.2 cm ID, 5 lm particle size, 300 Å pore size; Rockland Technologies, Wilmington, DE, USA). Elution was from 0 to 70% B, 1% B/ min gradient rate, 0.3 mL/min flow rate, where A ¼ 0.05% aqueous TFA and B ¼ 0.05% TFA in acetonitrile. Peaks were detected by absorbance at 210 nm.
Permeabilization of outer membranes
to N-phenyl-1-napthylamine
The ability of peptides to increase outer membrane permeability of gram-negative bacteria was determined by measuring incorporation of the fluorescent dye N-phenyl-1-napthylamine (NPN) into the outer membrane of E. coli UB1005 (15) . Permeabilization studies were carried out as described previously (16, 17) . Briefly, E. coli UB1005 cells were suspended in 5 mm sodium HEPES buffer, pH 7.0, 
Results
Peptide design
The peptide sequences used in this study were based on the GS14 sequence (10) Peptide Name Sequence Our main objective in this study was to investigate the role of the hydrophobicity of d-amino acid substitutions at position 4 of GS14 on biologic specificity between microbial cells and human cells.
GS14X L 4 series 2 4 6 8 10 12 14
GS14 cyclo -VKLKVYPLKVKLYP GS14L L 4 cyclo ----L---------- GS14F L 4 cyclo ----F---------- GS14Y L 4 cyclo ----Y---------- GS14N L 4 cyclo ----N---------- GS14X D 4 series GS14K D 4 cyclo ----K---------- GS14L D 4 cyclo ----L---------- GS14F D 4 cyclo ----F---------- GS14Y D 4 cyclo ----Y---------- GS14N D 4 cyclo ----N---------- GS14G4 cyclo ----G----------
Circular dichroism spectroscopy
We examined secondary structures of GS14X4 peptides in benign and membrane-mimicking solvents (see Materials and Methods). GS14X l 4 peptides form b-sheet structures in benign conditions, as shown by their CD spectra with local minima at 205 and 220 nm (Fig. 3A) . The spectra of these peptides are not characteristic of conventional b-sheet spectra due to the major contribution of the type II¢ b-turns to molar ellipticity at $205 nm, and appear similar to the representative spectrum of an a-helix (14); therefore, an estimate of per cent b-sheet could not be calculated. In addition, the aromatic amino acid tyrosine, present in all peptide analogs in this study, influences the far-UV CD spectra (22-24). However, the NMR solution structures of GS14 and GS14K d 4 have previously been determined (21) and show the respective b-sheet and disrupted b-sheet conformations that correspond to the helix-like CD spectra of these peptides.
In 50% TFE, the GS14X l 4 peptides became more structured, as indicated by the increase in negative molar ellipticity observed, e.g. in GS14L l 4 ( Fig. 3A ; Table 1 In comparing retention times between GS14X l 4 and GS14X d 4 peptides, those that were more retentive than their respective diastereomers were consistent with sequences possessing a higher amphipathic character, i.e.
containing either nonpolar d-substitutions on the nonpo- 
Hemolytic activity
All l-diastereomers and GS14G4 were strongly hemolytic ( Table 3) . d-diastereomers were generally less hemolytic when the substituted amino acid was very polar (d-Asn and d-Lys), with GS14K d 4 being the most polar and the least hemolytic peptide in this study (Fig. 5) . Hemolytic activity was strong for both d-and l-substitutions with the nonpolar amino acids Leu and Phe, likely because these amino acids did not reduce the hydrophobicity of the nonpolar face (Fig. 4, top) The peptide with the best TI against gram-negative bacteria and yeast was GS14K d 4 ( Fig. 6 ; Table 3 ). We observed both improved antimicrobial activity vs. gram-negative bacteria and decreased hemolytic activity for GS14K d 4 compared with its diastereomer, GS14 ( Table 3 ; Fig. 5 ). 
Peptide-lipid interactions
Peptides were evaluated for their ability to interact with membranes and membrane components in the fluorescence-based NPN uptake and diSC 3 (5) release assays (see
Materials and Methods). While the NPN uptake studies
showed peptide permeabilizing effects on the outer membrane of gram-negative bacteria (Fig. 7) , the diSC 3 (5) release assay indicated the peptides ability to disrupt the membrane potential across the inner cytoplasmic membrane (Fig. 8) .
The NPN uptake results showed that all of the peptides except GS14N l 4 were able to permeabilize the outer membrane to a similar degree (Fig. 7) . The greatest differ- Although there were few differences between d-and l-diastereomers in increasing outer membrane permeability, we observed more differences in diastereomers influencing the permeability of the cytoplasmic membrane. In the diSC 3 (5) assay, all of the d-diastereomers except GS14-K d 4 released more dye than GS14G4 at their respective MIC concentrations, while all of the l-diastereomers released less dye than GS14G4, indicating that the d-diastereomers
were generally more disruptive to the cytoplasmic membrane potential than the l-diastereomers (Fig. 8) . The Table 3 . Biologic activity of GS14 analogs against yeast and gram-negative bacteria Tables 3 and 4 . Peptides with l-amino acids or Gly substituted at position 4 displayed strong hemolytic activity and poor antimicrobial activity, resulting in a low therapeutic index (<1), and were omitted from graphs (see Tables 3 and 4 for activity values).
relative to the disrupted b-sheet structure of the d-diastereomers. Among the peptides substituted with d-amino acids, the most disruptive peptide was GS14F d 4 (d-Phe substitution), one of the most hydrophobic peptides in this study (Fig. 4) , while the weakest was GS14K d 4, which also exhibited the best antimicrobial activity against the outermembrane permeable E. coli DC2 cells used in the diSC 3 (5) assay ( Table 3) . Although poor cytoplasmic membrane depolarization ability is not correlated with either strong or weak antimicrobial activity in this study, the results for GS14K d 4 suggest that the ability to depolarize the cytoplasmic membrane is not a requirement for strong antimicrobial activity.
Discussion
Our main objective in this study was to investigate the role overall hydrophobicity, amphipathicity, and the degree of secondary (b-sheet) structure in benign medium.
Overall inherent hydrophobicity
Previous studies have shown that for antimicrobial peptides in various structural categories, the hydrophobicity of the peptide must exceed a minimal value to exert antimicrobial and hemolytic activity. The differences between this minimal hydrophobicity value for microbial cells and human cells provide a window that allows the development of peptides with selectivity toward microbial membranes (31).
However, as hydrophobicity increases beyond a certain value, selectivity is lost as peptides become both strongly c. Bacterial strain assayed. S. aureus is wild-type Staphylococcus aureus strain 25923; S. aureus 2 is methicillin-resistant strain SAP0017; S. epidermidis is wild-type strain C621; B. subtilis is wild-type Bacillus subtilis. e. Therapeutic index, calculated as hemolytic activity (lg/mL)/MIC (lg/mL). MIC values that exceeded the highest concentration tested were arbitrarily assigned the value 128 lg/mL for calculations. f. Gain or improvement in therapeutic index for GS14XD4 over GS14XL4 diastereomers. Gain is calculated as (therapeutic index, D-diastereomer)/(therapeutic index, L-diastereomer).
The largest improvement in specificity of the D-peptide over the L-peptide is italicized. (Fig. 4) .
Amphipathicity
Amphipathicity is a known requirement for antimicrobial activity in helical peptides (34) and highly amphipathic molecules have been shown to increase specificity toward mammalian membranes. In agreement with these findings, the highly amphipathic GS14 peptide ( Fig. 2) with four lysine residues on the hydrophilic face and six large hydrophobes (three Val and three Leu residues) on the hydrophobic face had reduced antimicrobial activity, and was very hemolytic (14) . Interestingly, GS14K d 4 ( to reduce amphipathicity over GS14, and significantly improves the TI over GS14.
Secondary structure
The induction of secondary structure in passing from an aqueous environment to the hydrophobic membrane environment has been observed to increase microbial specificity in helical peptides (35) . We have previously observed that d-amino acid substitution in GS14, which disrupts b-sheet structure in benign medium but allows induction of structure in hydrophobic medium, serves to reduce peptide binding affinity to bacterial lipopolysaccharide, reduce amphipathicity, weaken hemolytic activity and strengthen antimicrobial activity (14) . These results suggest that this change in structure from benign to hydrophobic medium is important. However, others have shown that diastereomers of helical peptides substituted with d-amino acids displayed little or no secondary structure in benign medium, and exhibited reduced hemolytic activity and retained antimicrobial activity over their l-counterparts without requiring secondary structure in a hydrophobic environment (36, 37) .
In the same studies, preformed secondary structure in benign medium can unfavorably increase specificity for mammalian membranes. This is in contrast with the results for a cyclic b-sheet peptide which is also preformed in benign medium, yet had excellent specificity for microbial cells (21). Substitution of d-amino acids is known to be disruptive to secondary structure of linear a-helical peptides 
